128 related articles for article (PubMed ID: 38335726)
1. New Alpha9 nAChR Ligands Based on a 5-(Quinuclidin-3-ylmethyl)-1,2,4-oxadiazole Scaffold.
Dallanoce C; Richter K; Stokes C; Papotto C; Andleeb H; Thakur GA; Kerr A; Grau V; Papke RL
ACS Chem Neurosci; 2024 Feb; 15(4):827-843. PubMed ID: 38335726
[TBL] [Abstract][Full Text] [Related]
2. Selective Agonists and Antagonists of α9 Versus α7 Nicotinic Acetylcholine Receptors.
Papke RL; Andleeb H; Stokes C; Quadri M; Horenstein NA
ACS Chem Neurosci; 2022 Mar; 13(5):624-637. PubMed ID: 35167270
[TBL] [Abstract][Full Text] [Related]
3. Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.
Quadri M; Silnović A; Matera C; Horenstein NA; Stokes C; De Amici M; Papke RL; Dallanoce C
Eur J Med Chem; 2018 Dec; 160():207-228. PubMed ID: 30342362
[TBL] [Abstract][Full Text] [Related]
4. Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10.
Zakrzewicz A; Richter K; Agné A; Wilker S; Siebers K; Fink B; Krasteva-Christ G; Althaus M; Padberg W; Hone AJ; McIntosh JM; Grau V
Front Cell Neurosci; 2017; 11():189. PubMed ID: 28725182
[TBL] [Abstract][Full Text] [Related]
5. Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively.
Giraudo A; Pallavicini M; Bolchi C
Pharmacol Res; 2023 Jul; 193():106801. PubMed ID: 37236412
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and
Richter K; Papke RL; Stokes C; Roy DC; Espinosa ES; Wolf PMK; Hecker A; Liese J; Singh VK; Padberg W; Schlüter KD; Rohde M; McIntosh JM; Morley BJ; Horenstein NA; Grau V; Simard AR
Front Cell Neurosci; 2022; 16():779081. PubMed ID: 35431807
[TBL] [Abstract][Full Text] [Related]
7. Silent agonists for α7 nicotinic acetylcholine receptors.
Papke RL; Quadri M; Gulsevin A
Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
[TBL] [Abstract][Full Text] [Related]
8. Evidence of a dual mechanism of action underlying the anti-proliferative and cytotoxic effects of ammonium-alkyloxy-stilbene-based α7- and α9-nicotinic ligands on glioblastoma cells.
Pucci S; Bolchi C; Bavo F; Pallavicini M; De Palma C; Renzi M; Fucile S; Benfante R; Di Lascio S; Lattuada D; Bessereau JL; D'Alessandro M; Risson V; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2022 Jan; 175():105959. PubMed ID: 34756924
[TBL] [Abstract][Full Text] [Related]
9. Distinctive Roles for α7*- and α9*-Nicotinic Acetylcholine Receptors in Inflammatory and Autoimmune Responses in the Murine Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis.
Liu Q; Whiteaker P; Morley BJ; Shi FD; Lukas RJ
Front Cell Neurosci; 2017; 11():287. PubMed ID: 29018331
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice.
Lykhmus O; Voytenko LP; Lips KS; Bergen I; Krasteva-Christ G; Vetter DE; Kummer W; Skok M
Front Cell Neurosci; 2017; 11():282. PubMed ID: 28955208
[TBL] [Abstract][Full Text] [Related]
11. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
[TBL] [Abstract][Full Text] [Related]
12. Differential involvement of α4β2, α7 and α9α10 nicotinic acetylcholine receptors in B lymphocyte activation in vitro.
Koval L; Lykhmus O; Zhmak M; Khruschov A; Tsetlin V; Magrini E; Viola A; Chernyavsky A; Qian J; Grando S; Komisarenko S; Skok M
Int J Biochem Cell Biol; 2011 Apr; 43(4):516-24. PubMed ID: 21146628
[TBL] [Abstract][Full Text] [Related]
13. Calcium imaging with genetically encoded sensor Case12: Facile analysis of α7/α9 nAChR mutants.
Shelukhina I; Spirova E; Kudryavtsev D; Ojomoko L; Werner M; Methfessel C; Hollmann M; Tsetlin V
PLoS One; 2017; 12(8):e0181936. PubMed ID: 28797116
[TBL] [Abstract][Full Text] [Related]
14. α9- and α7-containing receptors mediate the pro-proliferative effects of nicotine in the A549 adenocarcinoma cell line.
Mucchietto V; Fasoli F; Pucci S; Moretti M; Benfante R; Maroli A; Di Lascio S; Bolchi C; Pallavicini M; Dowell C; McIntosh M; Clementi F; Gotti C
Br J Pharmacol; 2018 Jun; 175(11):1957-1972. PubMed ID: 28726253
[TBL] [Abstract][Full Text] [Related]
15. Subnanomolar Affinity and Selective Antagonism at α7 Nicotinic Receptor by Combined Modifications of 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624).
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Oh H; Kneisley DL; Eaton B; Lucero L; Gotti C; Clementi F; Whiteaker P; Bolchi C
J Med Chem; 2023 Jan; 66(1):306-332. PubMed ID: 36526469
[TBL] [Abstract][Full Text] [Related]
16. α7- and α9-Containing Nicotinic Acetylcholine Receptors in the Functioning of Immune System and in Pain.
Shelukhina I; Siniavin A; Kasheverov I; Ojomoko L; Tsetlin V; Utkin Y
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047495
[TBL] [Abstract][Full Text] [Related]
17. Choline and nicotine increase glioblastoma cell proliferation by binding and activating α7- and α9- containing nicotinic receptors.
Pucci S; Fasoli F; Moretti M; Benfante R; Di Lascio S; Viani P; Daga A; Gordon TJ; McIntosh M; Zoli M; Clementi F; Gotti C
Pharmacol Res; 2021 Jan; 163():105336. PubMed ID: 33276105
[TBL] [Abstract][Full Text] [Related]
18. Mammalian nicotinic receptors with alpha7 subunits that slowly desensitize and rapidly recover from alpha-bungarotoxin blockade.
Cuevas J; Berg DK
J Neurosci; 1998 Dec; 18(24):10335-44. PubMed ID: 9852571
[TBL] [Abstract][Full Text] [Related]
19. A silent agonist of α7 nicotinic acetylcholine receptors modulates inflammation ex vivo and attenuates EAE.
Godin JR; Roy P; Quadri M; Bagdas D; Toma W; Narendrula-Kotha R; Kishta OA; Damaj MI; Horenstein NA; Papke RL; Simard AR
Brain Behav Immun; 2020 Jul; 87():286-300. PubMed ID: 31874200
[TBL] [Abstract][Full Text] [Related]
20. From 2-Triethylammonium Ethyl Ether of 4-Stilbenol (MG624) to Selective Small-Molecule Antagonists of Human α9α10 Nicotinic Receptor by Modifications at the Ammonium Ethyl Residue.
Bavo F; Pallavicini M; Pucci S; Appiani R; Giraudo A; Eaton B; Lucero L; Gotti C; Moretti M; Whiteaker P; Bolchi C
J Med Chem; 2022 Jul; 65(14):10079-10097. PubMed ID: 35834819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
